In solid tumors, neoadjuvant or adjuvant immune checkpoint blockade increases treatment-related grade 3 or 4 adverse events

被引：0
|
作者：
Bertolaccini, Luca [1 ]
机构：
[1] European Inst Oncol IRCCS, IEO, Milan, Italy
来源：
ANNALS OF INTERNAL MEDICINE | 2024年 / 177卷 / 04期
关键词：
D O I：
10.7326/J24-0013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Source Citation Fujiwara Y, Horita N, Adib E, et al. Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials. Lancet Oncol. 2024;25:62-75. 38012893 Clinical Impact Ratings GIM/FP/GP: Oncology:
引用
收藏
页码：JC42 / JC42
页数：1
相关论文
共 50 条
  • [1] Treatment-related adverse events as surrogate to response rate to immune checkpoint blockade
    Shen, Yanyun
    Chen, Yunfeng
    Wang, Duoqin
    Zhu, Zhidong
    MEDICINE, 2020, 99 (37)
  • [2] Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials
    Fujiwara, Yu
    Horita, Nobuyuki
    Adib, Elio
    Zhou, Susu
    Nassar, Amin H.
    Asad, Zain U. L. Abideen
    Cortellini, Alessio
    Naqash, Abdul Rafeh
    LANCET ONCOLOGY, 2024, 25 (01): : 62 - 75
  • [3] Treatment-related adverse events and response rate to immune checkpoint inhibition
    Li, Yanmin
    Wang, Zhengping
    Guo, Ting
    Liu, Shenghua
    Feng, Chenchen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
  • [4] Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
    Postow, Michael A.
    Sidlow, Robert
    Hellmann, Matthew D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 158 - 168
  • [5] Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review
    Ouyang, Tao
    Cao, Yanyan
    Kan, Xuefeng
    Chen, Lei
    Ren, Yanqiao
    Sun, Tao
    Yan, Liangliang
    Xiong, Bin
    Liang, Bin
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Gastrointestinal treatment-related adverse events of combined immune checkpoint inhibitors: a meta-analysis
    Karna, Rahul
    S Deliwala, Smit
    Ramgopal, Balasubramanian
    Asawa, Palash
    Mishra, Rahul
    P Mohan, Babu
    Jayakrishnan, Thejus
    Grover, Dheera
    Kalra, Tanisha
    Bhalla, Jaideep
    Saraswati, Ushasi
    Gangwani, Manesh K.
    Dhawan, Manish
    Adler, Douglas G.
    IMMUNOTHERAPY, 2023, 15 (10) : 773 - 786
  • [7] Immune-related adverse events with immune checkpoint blockade: a comprehensive review
    Michot, J. M.
    Bigenwald, C.
    Champiat, S.
    Collins, M.
    Carbonnel, F.
    Postel-Vinay, S.
    Berdelou, A.
    Varga, A.
    Bahleda, R.
    Hollebecque, A.
    Massard, C.
    Fuerea, A.
    Ribrag, V.
    Gazzah, A.
    Armand, J. P.
    Amellal, N.
    Angevin, E.
    Noel, N.
    Boutros, C.
    Mateus, C.
    Robert, C.
    Soria, J. C.
    Marabelle, A.
    Lambotte, O.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : 139 - 148
  • [8] High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
    Kuo, Alyce M.
    Markova, Alina
    FRONTIERS IN MEDICINE, 2022, 9
  • [9] The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review
    Moujaess, Elissar
    Haddad, Fady Gh
    Eid, Roland
    Kourie, Hampig Raphael
    IMMUNOTHERAPY, 2019, 11 (16) : 1409 - 1422
  • [10] Treatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis
    Park, Robin
    Lopes, Laercio
    Cristancho, Cagney R.
    Riano, Ivy M.
    Saeed, Anwaar
    FRONTIERS IN ONCOLOGY, 2020, 10
12345